Pulmonary lymphoma of mucosa-associated lymphoid tissue type followed as a long-standing indeterminate lesion in immunoglobulin M-type paraproteinemia

2006 ◽  
Vol 54 (7) ◽  
pp. 293-296 ◽  
Author(s):  
Yasushi Sakamaki ◽  
Hyung-Eun Yoon ◽  
Naofumi Oda ◽  
Hisao Uejima ◽  
Masami Imakita
2001 ◽  
Vol 21 (3) ◽  
pp. 174-180 ◽  
Author(s):  
Tomoo Itoh ◽  
Michio Shimizu ◽  
Koichi Kitami ◽  
Kyosuke Kamata ◽  
Kenji Mitsumori ◽  
...  

2012 ◽  
Vol 16 (3) ◽  
pp. 224-229 ◽  
Author(s):  
Shin-ichi Nakatsuka ◽  
Teruaki Nagano ◽  
Hayato Kimura ◽  
Shoji Hanada ◽  
Hidetoshi Inoue ◽  
...  

CHEST Journal ◽  
2011 ◽  
Vol 139 (3) ◽  
pp. 724-725 ◽  
Author(s):  
Andrés J.M. Ferreri
Keyword(s):  

Open Medicine ◽  
2019 ◽  
Vol 14 (1) ◽  
pp. 757-760 ◽  
Author(s):  
Antonello Sica ◽  
Paola Vitiello ◽  
Alfonso Papa ◽  
Armando Calogero ◽  
Caterina Sagnelli ◽  
...  

AbstractAdministration of rituximab, one of the basic drugs for the therapy of B-cell lymphoproliferative diseases, during pregnancy has been suspected to cause developmental fetal events, particularly if given during the first trimester of pregnancy. Therefore, use in pregnancy is not permitted. Howe ver, several cases of pregnant women being treated with rituximab are reported herein; an exception is often made in cases with grave illness.We describe an exceptional case of a woman with non-Hodgkin lymphoma of the mucosa-associated lymphoid tissue type where rituximab was given as a single agent without interruption during two consecutive pregnancies. This case can certainly supply important indications on the safety of rituximab.


Digestion ◽  
2002 ◽  
Vol 65 (4) ◽  
pp. 196-199 ◽  
Author(s):  
Friedrich Vorbeck ◽  
Christian Österreicher ◽  
Andreas Püspök ◽  
Brigitte Dragosics ◽  
Wolfgang Fiebiger ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document